AI-generated summary
In this randomized split-face study, the authors compared five weekly low-fluence Q-switched Nd:YAG laser sessions combined with isobutylamido thiazolyl resorcinol (ITR) cream on one side against laser plus placebo cream on the other side in 24 patients with facial hyperpigmentation. The authors report greater improvement in lightness index and severity score on the ITR side at week 4, with partial recurrence on both sides and no serious side effects.
- Participants
- 24
- Who or what was studied
- Patients with symmetrical facial hyperpigmentation
- Wavelengths
- 1064 nm
- Limits stated in the abstract
- The abstract reports only 24 completers, a single-center design with 8 weeks of follow-up after the last laser session, and does not describe long-term outcomes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.